Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel.
about
The effect of ABCB1 polymorphisms on the outcome of breast cancer treatmentImpact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy.Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients.Advances and challenges in hereditary cancer pharmacogenetics.ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cellsClinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients.Genetics of the patent ductus arteriosus (PDA) and pharmacogenetics of PDA treatment.Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer
P2860
Q26749954-F6B5FD57-C020-49C2-8950-61C13E64435CQ33441706-1E64ECAF-CB5C-45CC-803E-5779C3D93C8AQ37687072-2D48B0DD-93D4-44BF-9E5A-0173B0EC86E4Q38948499-BAC45248-5476-47DD-B7D2-CE835743F1DBQ41548025-D86D3F3D-C234-4EC7-B87A-9934EB414BE3Q49136273-3521A9CC-8903-4ED7-A960-57DFD41F4503Q50420641-A155E965-4DC9-4619-B50A-9490FF49E534Q57106074-3E01AC1D-59DF-4EA5-8BA9-E4A6644CD6C1
P2860
Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Impact of genetic variability ...... clophosphamide, and docetaxel.
@en
Impact of genetic variability ...... clophosphamide, and docetaxel.
@nl
type
label
Impact of genetic variability ...... clophosphamide, and docetaxel.
@en
Impact of genetic variability ...... clophosphamide, and docetaxel.
@nl
prefLabel
Impact of genetic variability ...... clophosphamide, and docetaxel.
@en
Impact of genetic variability ...... clophosphamide, and docetaxel.
@nl
P2093
P2860
P1476
Impact of genetic variability ...... clophosphamide, and docetaxel.
@en
P2093
A S Dieudonné
C Vulsteke
H Wildiers
M Schwenkglenks
R Paridaens
R Pettengell
P2860
P2888
P304
P356
10.1007/S10549-014-3105-5
P407
P577
2014-08-29T00:00:00Z
P6179
1052166571